InnoVax Forum: Vaccine Development and Manufacturing Forum 2017

Event Date: Nov.15-16, 2017

Event Hotel: Renaissance Shanghai Yu Garden Hotel

Event Website: http://www.innovaxsummit.com

 

Partial Keynote Speakers & Topics

Presentation Topic: The Future Landscape of Vaccine Product Development

Margaret Liu, Principal, ProTherImmune; President of International Society of Vaccines

 

Presentation Topic: Emerging Infectious Diseases and the Role of Gene-based Vaccine

Margaret Liu, Principal, ProTherImmune; President of International Society of Vaccines

 

Presentation Topic: Cutting-edge Science towards Next Generation Adjuvant and Immunotherapeutic Agent

Ken Ishii, Director, Center for Vaccine and Adjuvant Research, NIBIOHN, Professor, Osaka University

 

Presentation Topic: NeoAntigen Based Cancer Vaccine: a brighter future of cancer immunotherapy

John Wang, CEO, ImmuOn Therapeutics

 

Presentation Topic: Evaluation of antibody quality elicited by a replication defective HCMV vaccine

Sha Ha, Director, Vaccine BioProcess R&D, Merck & Co., USA

 

Presentation Topic: Future Prospects and Application for the Development of Adenovirus-based Vaccine

Xuefeng Yu, President and CEO, CanSinoBio

 

Presentation Topic: Therapeutic Vaccine Development against Chronic Hepatitis B Virus Infection

Jung-sung Yum, Executive Director, CHA Vaccine Institute

 

Presentation Topic: New Generation Therapeutic Vaccine

Teddy Choe, President and Director, Mogam Institute for Biomedical Research

 

Presentation Topic Global Market and Technology Trends in Vaccine BioProcessing

Guenter Jagschies, Senior Director, GE Life Sciences

 

For more up-to-date speakers committee, please visit http://www.innovaxsummit.com/Speakers.asp

 

Program Key Discussions

Vaccine Industry and Product Development

▪ Recent Trends and Development for Vaccine Industry and Product Development

▪ China/Asian Vaccine R&D and Industry Outlook and Partnership

▪ The Evolution of Regulatory System and Adherence to International Standards

▪ New Technologies for Vaccine Research

▪ Vaccine Adjuvant Technology and Therapeutic Vaccine Development

▪ Viral Challenge Studies and Clinical Development

▪ Novel Vaccine Delivery System, Formulation and Cold Chain Management

 

Vaccine Process Development and Manufacturing Excellence

▪ Challenges and Trends in Vaccine Manufacturing

▪ New/Alternative Manufacturing Platform for Vaccine Production

▪ Current and Emerging Cell Culture Manufacturing Technologies for Vaccine Products

▪ Single-use Systems, Multiple-Products Facility and Flexible Manufacturing

▪ Analytical Characterization, Control and Purification Development

▪ QbD, PAT and High-throughput Vaccine Process Development

 

For more information about the speaking and participation options, please contact:

 

Wei Zhang

Program Manager

wzhang@deliver-consulting.com

Direct: 86.21.6034.0229

Organizing and Planning Committee

InnoVax Forum 2017 (Vaccine Development and Manufacturing Forum)